In an effort to assist their customers, and potential customers, to understand the scope of Patent # 5,804,596, Sabinsa Corporation requested its legal counsel,...Read More
Latest Press Releases
Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
April 4, 2019
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Process and compositions for.
Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research
January 19, 2016
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s.
Sabinsa Introduces Softgel Ready ForsLean® Soft Extracts Amid Exponential Growth In Coleus Demand: Company Cautions Against Low Quality Spam Knockoffs
July 8, 2014
Just in time for legitimate dietary supplement manufacturers to differentiate their products from the inferior spamtouted forskolin products driven by Dr. Oz and SPAM emails,.
Sabinsa Corporation announces that its popular dietary supplement ingredient ForsLean®, a standardized extract from Coleus forskholii roots patented by Sabinsa...Read More